Pharmacist Protocols and Collaborative Practice

Sample Immunization Protocol

As of Noon on October 14, 2022, the Kansas Statewide Immunization Protocol is no longer effective and should not be used to immunize Kansas patients. If you have previously signed and provided vaccines under the protocol, please retain a copy of the dually signed protocol for at least five years at the location where any vaccine was provided under the authority of the protocol.

Pharmacists planning to continue providing immunizations to patients may use the following methods:

1. Pharmacists may enter into an immunization protocol with a Kansas-licensed physician to administer vaccines or authorize pharmacist interns to administer vaccines. A sample immunization protocol is provided below. The 2021 updates to the Kansas Pharmacy Practice Act require any immunization protocol be signed by the authorizing physician and the administering pharmacist. Copies of the signed protocol should be retained for five years at the location(s) where immunizations are provided, but do not need to be sent to the Board office.
Sample Immunization Protocol (Word)
Sample Immunization Protocol (pdf)

2. Under the Federal PREP Act, pharmacists may independently order and administer FDA-approved vaccines to children ages 3-18 years, influenza vaccines to persons 19 years and older pursuant to the CDC/ACIP standard immunization schedule, and order and administer FDA-authorized or FDA-licensed COVID-19 vaccines to persons 3 years or older. Furthermore, pharmacist interns and pharmacy technicians may administer these immunizations under the direct supervision of the pharmacist who has ordered the immunization. Participating pharmacists, interns, and technicians must:

  • Complete an ACPE immunization certification course;
  • Have a current CPR certificate;
  • Complete a 2-hour, ACPE-approved continuing education course in immunizations within the current state license period;
  • Comply with Kansas immunization recordkeeping and reporting requirements, including informing the patient’s primary-care provider, submitting to Kansas WebIZ, reporting adverse events, and complying with requirements whereby the person administering a vaccine must review the vaccine registry or other vaccination records prior to administering a vaccine. See K.S.A. 65-1635a; and
  • Inform any pediatric patient and the patient’s adult caregivers of the importance of a well-child visit with a pediatrician or other licensed primary care provider and refer patients as appropriate.
3. To alleviate any potential for patient harm, patients needing a second vaccine to complete a series initiated under the previous statewide protocol should be administered that vaccine in accordance with that protocol.  For example, this means that those patients who need the second in the Zoster series should be able to receive the vaccine.

Sample Collaborative Practice Agreements

Helpful Tools and Resources

Collaborative Drug Therapy Management Committee Members

Erick Axcell, PharmD, Non-Voting Chair
Meghan Haftman, PharmD
Anthony Caracci, PharmD
Chad Ullom,RPh
Michael Machen, MD
Lynn Fisher, MD
G. Aron Fast, MD